All articles by Allie Nawrat

Collaboration not competition: is big pharma and big tech a recipe for success?

Collaboration has widely been deemed a silver lining of the Covid-19 pandemic. The word ‘unprecedented’ has certainly been overused in…
Public benefit: could the PBC model help pharma balance profits and patients?

For centuries, there were two main ways to operate a business: as a for-profit corporation or as a non-profit company.…
Q&A: staving off AMR disaster with Ineos and the University of Oxford

The Covid-19 pandemic has taught the world that viruses evolve and mutate to evade the immune system with dangerous consequences.…
Exploring the Covid-19 vaccine IP waiver proposal at the WTO

On 11 March 2020, the World Health Organization (WHO) declared the escalating coronavirus crisis to be a pandemic. Fast forward…
Coronavirus company news summary – the EC approves J&J’s Covid-19 vaccine – Pfizer/BioNTech’s vaccine found to be 97% effective after two doses in Israeli real-world study

12 March 2021 Israel's Ministry of Health, Pfizer and BioNTech announced that real-world evidence demonstrates lower incidence of Covid-19 disease among…

EMA approves fourth Covid-19 vaccine, J&J’s single-shot candidate

The European Medicines Agency (EMA) has recommended conditional marketing authorisation for Johnson & Johnson (J&J) subsidiary Janssen’s Covid-19 vaccine. Janssen’s…
Denmark suspends AZ/Oxford Covid-19 vaccination amid blood clot concerns

The Danish National Board of Health has temporarily paused the roll-out of the AstraZeneca/Oxford Covid-19 vaccine. This is a precautionary…
Exscientia raises $100m Series C funding to develop fully autonomous drug design

Within nine months of closing a $60m Series C round, Oxford-headquartered artificial intelligence (AI) drug discovery company Exscientia has raised…
Coronavirus company news summary – Moderna starts studying modified vaccines targeting variants – CEPI to support VBI’s variant vaccine development

11 March 2021 The Coalition for Epidemic Preparedness Innovations (CEPI) and biopharmaceutical company VBI Vaccines have entered into a partnership…
UK denies EU accusations of Covid-19 vaccine export bans

The UK and the European Union (EU) are embroiled in a public diplomatic row about Covid-19 vaccine exports. European Council…